XML 80 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets and Goodwill (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Intangible assets            
Contingent consideration impairment $ 15.6   $ 29.0 $ 49.1 $ 23.5  
Total intangible assets, gross 7,607.2     7,607.2   $ 8,220.8
Accumulated Amortization (5,320.4)     (5,320.4)   (5,136.5)
Intangible assets, net 2,286.8     2,286.8   3,084.3
Amortization and impairment of acquired intangible assets 111.0   82.6 813.2 215.6  
Expected future amortization expense, 2019 (remaining three months) 70.0     70.0    
Expected future amortization expense, 2020 255.0     255.0    
Expected future amortization expense, 2021 210.0     210.0    
Expected future amortization expense, 2022 195.0     195.0    
Expected future amortization expense, 2023 195.0     195.0    
Expected future amortization expense, 2024 180.0     180.0    
Impairment of intangible assets       629.3 19.3  
Completed technology            
Intangible assets            
Cost 7,411.2     7,411.2   7,394.3
Net 2,090.8     2,090.8   2,257.8
Accumulated Amortization (5,320.4)     $ (5,320.4)   (5,136.5)
Completed technology | Minimum            
Intangible assets            
Estimated life, (in years)       4 years    
Completed technology | Maximum            
Intangible assets            
Estimated life, (in years)       28 years    
In-process research and development            
Intangible assets            
Amortization and impairment of acquired intangible assets 19.3     $ 19.3    
In-process research and development            
Intangible assets            
Indefinite lived intangible assets useful life       Indefinite until commercialization    
Cost and Net 132.0     $ 132.0   762.5
Accumulated Amortization 0.0     $ 0.0   0.0
Trademarks and Trade Names            
Intangible assets            
Indefinite lived intangible assets useful life       Indefinite    
Cost and Net 64.0     $ 64.0   64.0
Accumulated Amortization 0.0     0.0   $ 0.0
Vixotrigine            
Intangible assets            
Amortization and impairment of acquired intangible assets       44.3    
TGN | In-process research and development            
Intangible assets            
Cost and Net 132.0     132.0    
BIIB111            
Intangible assets            
Impairment of intangible assets 15.0     365.0    
BIIB111 | Nightstar            
Intangible assets            
Amortization and impairment of acquired intangible assets 15.0     365.0    
Impairment of intangible assets   $ 115.0        
BIIB112            
Intangible assets            
Impairment of intangible assets     $ 28.4 220.0 $ 220.0  
BIIB112 | Nightstar            
Intangible assets            
Amortization and impairment of acquired intangible assets 28.4     $ 220.0    
BIIB111 and BIIB112            
Intangible assets            
Manufacturing and other costs $ 39.1